Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Van Ness

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Leukemia|March 10, 2001
The bone marrow stromal microenvironment influences myeloma therapeutic response in vitroW C Cheung, B Van Ness
Leukemia|June 1, 2002
Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cellsW-C Cheung, B Van Ness
Leukemia|March 23, 1999
Interferon-alpha protects myeloma cell lines from dexamethasone-induced apoptosisP Liu, M Oken, B Van Ness
Nucleic Acids Research|February 25, 1990
Identification of a second inducible DNA-protein interaction in the kappa immunoglobulin enhancerK Nelms, R Hromas, B Van Ness
The Journal of Biological Chemistry|January 28, 1999
Developmental regulation of the kappa locus involves both positive and negative sequence elements in the 3' enhancer that affect synergy with the intron enhancerX Liu, A Prabhu, B Van Ness
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Induced kappa receptor editing shows no allelic preference in a mouse pre-B cell lineX Liu, M Linden, B Van Ness
Clinical Genetics|February 1, 1975
A new form of hereditary short limbed dwarfism with microcephalusR C Juberg, M B Van Ness
Blood|October 26, 2000
Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalanM Rowley, P Liu, B Van Ness
Monographs in Allergy|January 1, 1987
Experimental regulation of immunoglobulin synthesis and secretion in plasmacytoma and hybridoma cellsR G Lynch, A Mathur, B Van Ness
Advances in Experimental Medicine and Biology|January 1, 1987
Fc-specific suppressor T cellsA Mathur, B Van Ness, R G Lynch
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Leukemia|March 10, 2001
The bone marrow stromal microenvironment influences myeloma therapeutic response in vitroW C Cheung, B Van Ness
Leukemia|June 1, 2002
Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cellsW-C Cheung, B Van Ness
Leukemia|March 23, 1999
Interferon-alpha protects myeloma cell lines from dexamethasone-induced apoptosisP Liu, M Oken, B Van Ness
Nucleic Acids Research|February 25, 1990
Identification of a second inducible DNA-protein interaction in the kappa immunoglobulin enhancerK Nelms, R Hromas, B Van Ness
The Journal of Biological Chemistry|January 28, 1999
Developmental regulation of the kappa locus involves both positive and negative sequence elements in the 3' enhancer that affect synergy with the intron enhancerX Liu, A Prabhu, B Van Ness
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Induced kappa receptor editing shows no allelic preference in a mouse pre-B cell lineX Liu, M Linden, B Van Ness
Clinical Genetics|February 1, 1975
A new form of hereditary short limbed dwarfism with microcephalusR C Juberg, M B Van Ness
Blood|October 26, 2000
Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalanM Rowley, P Liu, B Van Ness
Monographs in Allergy|January 1, 1987
Experimental regulation of immunoglobulin synthesis and secretion in plasmacytoma and hybridoma cellsR G Lynch, A Mathur, B Van Ness
Advances in Experimental Medicine and Biology|January 1, 1987
Fc-specific suppressor T cellsA Mathur, B Van Ness, R G Lynch
Pageof 7